BioPharmSignal logoBioPharmSignal

Biotech News

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

AtriCure (ATRC)AtriCureConference / presentation

MASON, Ohio --(BUSINESS WIRE)--May 27, 2026-- AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating

Related news

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

LMATLeMaitre Vascular2026-08-06 21:15 EST

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

DCTHDelcath Systems2026-07-28 20:01 EST

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

APYXApyx Medical2026-07-28 12:00 EST

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

AORTArtivion2026-06-10 20:10 EST

Artivion to Participate in the 2026 Truist Securities MedTech Conference

ATRCAtriCure2026-07-27 12:00 EST

AtriCure to Participate at Upcoming Investor Conferences

LUNGPulmonx2026-07-28 20:05 EST

Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

View all latest news

AtriCure

Atrial Fibrillation Surgery AtriCure develops medical devices and procedures for the surgical treatment of atrial fibrillation. Its products are used by cardiac surgeons to create controlled lesions that interrupt abnormal electrical pathways and restore a more regular heart rhythm. Ablation Technologies The Isolator Synergy Ablation...

Recent company news

ATRCAtriCure2026-07-27 12:00 EST

AtriCure to Participate at Upcoming Investor Conferences

ATRCAtriCure2026-07-23 20:01 EST

AtriCure Reports Second Quarter 2026 Financial Results

ATRCAtriCure2026-07-02 12:00 EST

AtriCure to Announce Second Quarter 2026 Financial Results

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

ATRCAtriCure2026-05-05 20:01 EST

AtriCure Reports First Quarter 2026 Financial Results

Stock data

Close
39.49 USD
Market cap
1.31B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States